Flat-rate GLP-1 programs lock in one monthly price across all doses; dose-based models charge more as titration progresses. We compare 12-month costs, breakeven points, and which structure saves money at maintenance doses.

FuturHealth publishes a $229/month medication floor plus $129.99 membership but does not disclose whether that price increases with dose titration. We explain what is documented, what remains unclear, and how PlexusDx pricing works at every dose level.

Lavender Sky Health charges higher prices when GLP-1 doses increase—brand Wegovy pill climbs from $199 to $349 monthly, and compounded medication "price varies by dose." PlexusDx holds one flat rate at every dose level.

GobyMeds charges three-month semaglutide bundles in dose-based tiers: $299 at low doses, $399 at mid-range, $499 at high doses. Your price rises by $100 per quarter each time you move up a tier. This analysis shows the 12-month cost at each tier and the predictability trade-off you accept or avoid.

Emerge Weight Loss uses six tiered prices for compounded tirzepatide injection, ranging from $224/month at 2.5 mg to $289/month at 15 mg—a $65/month increase as your dose climbs. PlexusDx charges a flat $289/month at every dose.

BrightMeds charges the same flat rate at every dose level for both compounded semaglutide and tirzepatide. The month-to-month price stays constant whether you remain at starter dosing or titrate to maintenance levels.

OrderlyMeds advertises flat monthly GLP-1 rates after a two-month starter period. Whether those rates stay constant when your dose escalates—the evidence we captured does not answer directly. Here is what the data shows and where gaps remain.

TrimRx advertises semaglutide at $199/month, but checkout showed $299 on July 18, 2026. PlexusDx charges $189/month with no advertised-versus-actual gap. Both use dose-flat pricing; the savings compound across every plan length.